The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

Cell

Volumn 95, Issue 7, 1998, Pages 927-937

  Shiau, Andrew K ^a   Barstad, Danielle ^b   Loria, Paula M ^b   Cheng, Lin ^b   Kushner, Peter J ^c   Agard, David A ^a   Greene, Geoffrey L ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CRYSTAL STRUCTURE; LIGAND BINDING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TISSUE SPECIFICITY;

EID: 0032446607     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81717-1     Document Type: Article

References (59)

1. Adams, P.D., Pannu, N.S., Read, R.J., and Brünger, A.T. (1997). Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement. Proc. Natl. Acad. Sci. USA 94, 5018-5023.
2. Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J.M., and Meltzer, P.S. (1997). AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965-968.
3. Beato, M., Herrlich, P., and Schutz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857.
4. Berry, M., Metzger, D., and Chambon, P. (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818.
5. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382.
6. Brünger, A.T. (1996). X-PLOR Version 3.843 (New Haven, CT: Yale University).
7. Brzozowski, A., Pike, A., Dauter, Z., Hubbard, R., Bonn, T., Engstrom, O., Ohman, L., Greene, G., Gustafsson, J., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
8. CCP4. (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763.
9. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
10. Danielian, P., White, R., Lees, J., and Parker, M. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025-1033.
11. Ding, S., Anderson, C., Ma, H., Hong, H., Uht, R., Kushner, P., and Stallcup, M. (1998). Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12, 302-313.
12. Esnouf, R.M. (1997). An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15, 132-134.
13. Feng, W., Ribeiro, R.C., Wagner, R.L., Nguyen, H., Apriletti, J.W., Fletterick, R.J., Baxter, J.D., Kushner, P.J., and West, B.L. (1998). Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280, 1747-1749.
14. Furey, W., and Swaminathan, S. (1990). PA33. Am. Cryst. Assoc. Mtg. Abstr. 18, 73.
15. Glass, C.K., Rose, D.W., and Rosenfeld, M.G. (1997). Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232.
16. Gradishar, W.J., and Jordan, V.C. (1997). Clinical potential of new antiestrogens. J. Clin. Oncol. 15, 840-852.
17. Grainger, D.J., and Metcalfe, J.C. (1996). Tamoxifen: teaching an old drug new tricks? Nat. Med. 2, 381-385.
18. Greene, G., Nolan, C., Engler, J., and Jensen, E. (1980). Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. USA 77, 5115-5119.
19. Greene, G., Harris, K., Bova, R., Kinders, R., Moore, B., and Nolan, C. (1988). Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies. Mol. Endocrinol. 2, 714-726.
20. Grese, T.A., Sluka, J.P., Bryant, H.U., Cullinan, G.J., Glasebrook, A.L., Jones, C.D., Matsumoto, K., Palkowitz, A.D., Sato, M., Termine, J.D., et al. (1997). Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc. Natl. Acad. Sci. USA 94, 14105-14110.
21. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93, 11540-11545.
22. Heery, D., Kalkhoven, E., Hoare, S., and Parker, M. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.
23. Hegy, G., Shackleton, C., Carlquist, M., Bonn, T., Engstrom, O., Sjoholm, P., and Witkowska, H. (1996). Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids 61, 367-373.
24. Henttu, P.M., Kalkhoven, E., and Parker, M.G. (1997). AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17, 1832-1839.
25. Hong, H., Kohli, K., Trivedi, A., Johnson, D.L., and Stallcup, M.R. (1996). GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93, 4948-4952.
26. Horwitz, K.B., Jackson, T.A., Bain, D.L., Richer, J.K., Takimoto, G.S., and Tung, L. (1996). Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10, 1167-1177.
27. Huang, C.C., Pettersen, E.F., Klein, T.E., Ferrin, T.E., and Langridge, R. (1991). Conic: a fast renderer for space-filling molecules with shadows. J. Mol. Graph. 9, 230-236, 242.
28. Jordan, V.C. (1998). Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow. J. Natl. Cancer Inst. 90, 967-971.
29. Jordan, V.C., and Gosden, B. (1982). Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus. Mol. Cell. Endocrinol. 27, 291-306.
30. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.C., Heyman, R.A., Rose, D.W., Glass, C.K., and Rosenfeld, M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
31. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-actived protein kinase. Science 270, 1491-1494.
32. Kleywegt, G.J., and Jones, T.A. (1994). Halloween...masks and bones. In From First Map to Final Model, S. Bailey, R. Hubbard, and D. Waller, eds. (Warrington, England: SERC Daresbury Laboratory).
33. Korach, K. (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266, 1524-1527.
34. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J.A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870.
35. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., and Chambon, P. (1987). Functional domains of the human estrogen receptor. Cell 51, 941-951.
36. Le Douarin, B., Nielsen, A.L., Gamier, J.M., Ichinose, H., Jeanmougin, F., Losson, R., and Chambon, P. (1996). A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15, 6701-6715.
37. Li, H., Gomes, P.J., and Chen, J.D. (1997). RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94, 8479-8484.
38. Merritt, E.A., and Anderson, W.F. (1994). Raster3D Version 2.0: a program for photorealistic molecular structures. Acta Crystallogr. D 50, 219-220.
39. Moras, D., and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384-391.
40. Muller, K., Amman, H.J., Doran, D.M., Gerber, P.R., Gubernator, K., and Schrepfer, G. (1988). MOLOC: A molecular modeling program. Bull. Soc. Chim. Belg. 97, 655-667.
41. Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255.
42. Nicholls, A., Sharp, K., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
43. Norris, J.D., Fan, D., Stallcup, M.R., and McDonnell, D.P. (1998). Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology. J. Biol. Chem. 273, 6679-6688.
44. Onate, S.A., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor family. Science 270, 1354-1357.
45. Otwinowski, Z., and Minor, W. (1997). Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
46. Renaud, J., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D. (1995). Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
47. Robertson, D.W., Katzenellenbogen, J.A., Hayes, J.R., and Katzenellenbogen, B.S. (1982). Antiestrogen basicity - activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity. J. Med. Chem. 25, 167-171.
48. Seielstad, D., Carlson, K., Katzenellenbogen, J., Kushner, P., and Greene, G. (1995). Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Mol. Endocrinol. 9, 647-658.
49. Smigel, K. (1998). Breast cancer prevention trial shows major benefit, some risk. J. Natl. Cancer Inst. 90, 647-648.
50. Smith, E., Boyd, J., Frank, G., Takahashi, H., Cohen, R., Specker, B., Williams, T., Lubahn, D., and Korach, K. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331, 1056-1061.
51. Tanenbaum, D.M., Wang, Y., Williams, S.P., and Sigler, P.B. (1998). Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA 95, 5998-6003.
52. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., and Chambon, P. (1989). The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8, 1981-1986.
53. Torchia, J., Rose, D., Inostroza, J., Kamel, Y., Westin, S., Glass, C., and Rosenfeld, M. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
54. Tsai, M.J., and O'Malley, B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
55. Voegel, J.J., Heine, M.J.S., Zechel, C., Chambon, P., and Gronemeyer, H. (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667-3675.
56. Voegel, J.J., Heine, M.J., Tini, M., Vivat, V., Chambon, P., and Gronemeyer, H. (1998). The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17, 507-519.
57. Wallace, A.C., Laskowski, R.A., and Thornton, J.M. (1995). LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134.
58. Wrenn, C., and Katzenellenbogen, B. (1993). Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem. 268, 24089-24098.
59. Wurtz, J.M., Bourguet, W., Renaud, J.P., Vivat, V., Chambon, P., Moras, D., and Gronemeyer, H. (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3, 87-94. Cell, Vol. 95, 939-950, December 23, 1998,